黑素通过肠肝轴改善胆固醇性肝病
Xianjiao Liu1,2,3, Jinyan Li1,2,3, Mengdie Shi1,2,3
1College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, Jiangsu, China.
Journal of pineal research
|December 4, 2023
概括
黑素 (MT) 通过重塑肠道细菌和激活肠道FXR/FGF-15通路来改善胆固醇性肝病. 这种机制减少了小鼠的胆汁酸积累和肝损伤.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 胃肠病学 胃肠病学
- 内分泌学 在内分泌学.
背景情况:
- 胆固醇性肝病涉及肠道微生物群的破坏和有毒胆酸 (BA) 的积累.
- 黑素 (MT) 显示出治疗肝脏疾病的潜力,但其机制尚未完全理解.
研究的目的:
- 在胆固醇性肝病的小鼠模型中研究MT改善肝脏BA合成,肝损伤和纤维化的机制.
主要方法:
- 使用3,5-二氧化碳-1,4-二聚胺 (DDC) 养和Mdr2淘汰的小鼠模型.
- 给予MT和抗生素,进行便微生物群移植,并产生肠道上皮细胞特异性的FXR淘汰赛小鼠.
- 分析了肝损伤,纤维化,BA积累,肠道微生物群组成和便BA分泌.
主要成果:
- MT治疗显著降低了肝损伤和纤维化,降低了肝脏BA积累.
- MT重新编程了肠道微生物群,增强了便胆盐化酶活性,并增加了BA脱和分泌.
- MT激活了肠道FXR/FGF-15轴,抑制了肝脏BA合成,改善了肝纤维化,这种效果取决于肠道FXR.
结论:
- MT通过调节肠道微生物群和激活肠道FXR/FGF-15轴来改善胆固醇性肝病.
- 这种激活导致肝脏BA合成减少和BA分泌增加,提供肝脏保护的治疗机制.
相关概念视频
Hepatic Drug Excretion: Enterohepatic Cycling
1.5K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.5K
Cholesterol: Significance and Regulation
555
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
555
Hepatic Drug Excretion: Influencing Factors
133
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
133
Diseases of the Liver and Gallbladder
560
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
560
Factors Influencing Drug Absorption: Disease States and Pharmacology
532
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
532
Hepatic Drug Clearance: Role of Transporters
63
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
63


